查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
合成小分子 API 的市场规模、份额和趋势分析报告：按製造商（内部、外包）、应用（心血管、癌症）、地区、细分市场预测，2022-2030
市场调查报告书
商品编码
1133274

合成小分子 API 的市场规模、份额和趋势分析报告：按製造商（内部、外包）、应用（心血管、癌症）、地区、细分市场预测，2022-2030

Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Cardiology, Oncology), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

合成小分子 API 市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年，全球合成小分子 API 市场规模预计将达到 2171.7 亿美元。预计从 2022 年到 2030 年，市场的复合年增长率为 5.73%。这是由于全球对药品和新型小分子药物的需求不断增长。此外，跨剂型的小分子 API 的多功能性和易于纯化使其更易于接受和需求。

在製药行业，合成药物的比例正在增加，预计这将增加对小分子原料药等生产所需原材料的需求。此外，与增强现有产品相关的技术进步有望为小分子疗法提供新的机会。例如，2022年3月，赢创推出了一项增强口服小分子溶解度的新技术：EUDRATECSoluFlow。

市场受到每个地区政府对 API 生产的积极支持的推动，尤其是在亚洲，大多数 API 製造商依赖 API 供应来生产合成小分子 API。.原料药製造的外包活动也越来越受到关注。例如，2020 年 4 月，为了管理 COVID-19，Wavelength Pharmaceuticals 扩大了对呼吸系统重症患者管理所需的某些药物的关键活性成分的供应，并推出了 API CDMO 服务。中国、印度和东南亚等新兴市场代表着巨大的增长机会。

由于亚洲製造商专注于可大规模生产的低复杂性分子，因此对新技术和復杂技术的投资仍然相对较低。因此，投资高收益、低成本的技术是欧洲、北美等其他发达地区製造商规避竞争压力的一种选择。

市场上的主要参与者都专注于合作生产功能强大的 API 产品。例如，2021 年 8 月，Almac Sciences 与 Pila Pharma 就生产 API XEN-D0501（一种高活性和选择性的小分子 TRPV1 拮抗剂）达成协议。此外，CDMO 通过扩展其能力来不断发展，以满足对合成药物日益增长的需求。例如，2022 年 4 月，AGC Inc. 宣布扩建 7500 平方米的西班牙合成药物生产设施，预计这将提振该地区对合成小分子 API 的需求。

合成小分子 API 市场报告亮点

整体市场的增长是由于对原材料的需求增加导致药品产量增加。

API 市场正在经历一个重要的转折点，越来越倾向于使用 CDMO 大规模生产合成小分子 API

按製造商划分，由于中小企业依赖外包进行商业生产，预计外包行业在预测期内将显着增长

2021 年的市场细分以心血管领域为主。这是由于目标疾病的患病率越来越高

由于主要参与者的存在以及政府为提高该地区 API 製造能力而增加的政府支持，北美在 2021 年主导了市场

目录

u>

H3>

第 1 章合成小分子 API 市场：研究方法和范围

  • 市场细分
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • Gvr 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法按国家/地区进行市场预测
      • 方法 2：使用自上而下的方法估算各国市场
  • 全球市场：CAGR 计算
  • 区域市场：CAGR 计算
  • 二级信息列表
  • 目的
  • 缩写列表

第 2 章。合成小分子 API 市场：执行摘要

  • 合成小分子 API 市场：市场展望
    • 市场概览

第 3 章。合成小分子 API 市场：行业展望

  • 市场系列展望
    • 母市场谱系预测
    • 相关/子公司市场展望
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力
      • 医药行业高速增长
      • 增加新分子的研发和推出
      • 增加 API 生产外包
      • 不断增长的老年人口
      • 慢性病患病率
    • 市场製约因素分析
      • 生物製品的出现
      • 高度依赖亚洲国家的生产
  • SWOT 分析：按因素（政治和法律、经济和技术）
  • 行业分析：搬运工
  • 报销和监管方案
  • 重大交易和战略联盟
    • 推出新产品
    • 获取
    • 扩展名
    • 合作伙伴关係
    • 营销和推广

第 4 章。合成小分子 API 市场：竞争格局

  • 近期发展和影响分析：按主要市场进入者
    • Ansoff Matrix
  • 公司分类
    • 创新者
      • 市场差异化因素
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
    • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 竞争信息中心分析
  • 私人公司
    • 主要初创企业列表
  • Regional Network Map

第 5 章合成小分子原料药市场：製造商业务分析

  • 合成小分子原料药市场：製造商波动分析
  • 内部
  • 外包

第 6 章合成小分子 API 市场：应用业务分析

  • 合成小分子 API 市场：应用变化分析
  • 心脏病学
  • 肿瘤学
  • 中枢神经系统和神经病学
  • 骨科
  • 内分泌科
  • 呼吸内科
  • 肠胃科
  • 肾臟科
  • 眼科
  • 其他

第 7 章。合成小分子 API 市场：区域业务分析

  • 2021 年和 2030 年按国家/地区分列的市场份额分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章。合成小分子 API 市场：公司概况

  • 公司简介
    • AbbVie, Inc.
      • 会社概要
      • 财务实绩
      • 製品
      • 战略的
    • Bristol-Myers Squibb Company
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Boehringer Ingelheim International GmbH
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Cipla Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Teva Pharmaceutical Industries Ltd.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Albemarle Corporation
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Viatris Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Aurobindo Pharma
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Sun Pharmaceutical Industries Ltd.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Dr. Reddy's Laboratories Ltd.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
  • 他主要企业

Product Code: GVR-4-68039-976-3

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is expected to reach USD 217.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.73% from 2022 to 2030. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

  • The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material
  • The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk
  • By manufacturer, the outsourced segment is expected to witness lucrative growth over the forecast period owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • The cardiology appolication segment dominated the market in 2021. This is attributed to the increasing prevalence of target diseases
  • North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Table of Contents

Chapter 1 Synthetic Small Molecule API Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Synthetic Small Molecule API Market: Executive Summary

  • 2.1 Synthetic Small Molecule API Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Synthetic Small Molecule API Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 High growth of the pharmaceutical industry
      • 3.3.1.2 Rising R&D and launch of novel molecules
      • 3.3.1.3 Increased outsourcing of API production
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Escalating prevalence of chronic diseases
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Emergence of biologics
      • 3.3.2.2 High dependence on Asian nations for production
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Synthetic Small Molecule API Market: Competitive Landscape

  • 4.1 Recent developments & impact analysis, by key market participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Synthetic Small Molecule API Market: Manufacturer Business Analysis

  • 5.1 Synthetic Small Molecule API Market: Manufacturer Movement Analysis
  • 5.2 In-house
    • 5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion) (Volume, in Metric Tons)
  • 5.3 Outsourced
    • 5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)(Volume, in Metric Tons)

Chapter 6 Synthetic Small Molecule API Market: Application Business Analysis

  • 6.1 Synthetic Small Molecule API Market: Application Movement Analysis
  • 6.2 Cardiology
    • 6.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.3 Oncology
    • 6.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.4 CNS and Neurology
    • 6.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.5 Orthopedic
    • 6.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.6 Endocrinology
    • 6.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.7 Pulmonology
    • 6.7.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.8 Gastroenterology
    • 6.8.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.9 Nephrology
    • 6.9.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.10 Opthalmology
    • 6.10.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.11 Others
    • 6.11.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7 Synthetic Small Molecule API Market: Regional Business Analysis

  • 7.1 Market Share Analysis by Country, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2 Europe
      • 7.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.2 U.K.
      • 7.1.2.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.4 France
      • 7.1.2.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3 Asia Pacific
      • 7.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.3 China
      • 7.1.3.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.4 India
      • 7.1.3.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.5 South Korea
      • 7.1.3.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.6 Australia
      • 7.1.3.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4 Latin America
      • 7.1.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5 Middle East & Africa
      • 7.1.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Synthetic Small Molecule API Market: Company Profiling

  • 8.1 Company Profiles
    • 8.1.1 AbbVie, Inc.
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Bristol-Myers Squibb Company
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Boehringer Ingelheim International GmbH
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Cipla Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Teva Pharmaceutical Industries Ltd.
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Albemarle Corporation
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 Viatris Inc.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Aurobindo Pharma
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 Sun Pharmaceutical Industries Ltd.
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 Dr. Reddy's Laboratories Ltd.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial performance
      • 8.1.10.3 Product benchmarking
      • 8.1.10.4 Strategic initiatives
  • 8.2 List of Other Key Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global Synthetic Small Molecule API Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 6 Global Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 North America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 8 North America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 9 North America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 11 U.S. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 Canada Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 13 Canada Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 Europe Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 15 Europe Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 16 Europe Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Germany Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 18 Germany Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 U.K. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 20 U.K. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 21 France Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 22 France Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 23 Italy Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 24 Italy Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 25 Spain Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 26 Spain Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 Asia Pacific Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 29 Asia pacific Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 Japan Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Japan Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 32 China Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 China Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 India Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 35 India Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 South Korea Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 37 South Korea Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 38 Australia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 39 Australia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Latin America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 41 Latin America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 Latin America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 43 Brazil Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 44 Brazil Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Mexico Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 Mexico Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 47 Argentina Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 48 Argentina Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 49 Middle East & Africa Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 50 Middle East & Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Middle East & Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 52 Saudi Arabia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 53 Saudi Arabia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 54 South Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 South Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 UAE Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 57 UAE Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Synthetic small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Synthetic Small Molecule API market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Billion)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Synthetic small molecule API market driver impact
  • Fig. 14 Synthetic small molecule API market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Synthetic small molecule API market: manufacturer outlook and key takeaways
  • Fig. 19 Synthetic small molecule API market: manufacturer movement analysis & market share 2021 & 2030
  • Fig. 20 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Synthetic small molecule API market: application outlook and key takeaways
  • Fig. 23 Synthetic small molecule API market: application movement analysis & market share 2021 & 2030
  • Fig. 24 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 CNS and Neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Small Molecule API: Regional outlook and key takeaways
  • Fig. 35 Regional outlook, 2021 & 2030
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 U.K.
  • Fig. 45 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 France
  • Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Italy
  • Fig. 51 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 Spain
  • Fig. 53 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Asia Pacific
  • Fig. 55 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Japan
  • Fig. 57 Japan market estimates and forecast, 2018 - 2030(USD Billion)
  • Fig. 58 China
  • Fig. 59 China market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 India
  • Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 South Korea
  • Fig. 63 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Australia
  • Fig. 65 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Latin America
  • Fig. 67 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 68 Brazil
  • Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 70 Mexico
  • Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Argentina
  • Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 Middle East & Africa
  • Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 76 South Africa
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia
  • Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 80 UAE
  • Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 82 Ansoff Matrix
  • Fig. 83 Market differentiators
  • Fig. 84 Key company market share analysis, 2021
  • Fig. 85 Company market position analysis
  • Fig. 86 Competitive dashboard analysis
  • Fig. 87 Regional network map